Collagen vascular diseases

Medical Clinics of North America

Volumn 82, Issue 6, 1998, Pages 1217-1237

  Callen, J P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AURANOFIN; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLEOMYCIN; CALCIUM CHANNEL BLOCKING AGENT; CHLORAMBUCIL; CHLOROQUINE; CLOFAZIMINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DILTIAZEM; ERGOT ALKALOID; GLYCERYL TRINITRATE; HYDROXYCHLOROQUINE; ILOPROST; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; METHOTREXATE; NIFEDIPINE; PENICILLAMINE; PREDNISONE; RECOMBINANT ALPHA INTERFERON; SUNSCREEN; TRIAMCINOLONE ACETONIDE; TRYPTOPHAN; UNINDEXED DRUG;

COLLAGEN DISEASE; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; EOSINOPHILIA MYALGIA SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRALESIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS; ORAL DRUG ADMINISTRATION; POLYMYOSITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RETINOPATHY; REVIEW; SCLERODERMA; SKIN ATROPHY; SKIN LUPUS ERYTHEMATOSUS; TOPICAL DRUG ADMINISTRATION;

EID: 0031731366     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70414-4     Document Type: Article

References (38)

1. A. Bohan J.B. Peter Polymyositis and dermatomyositis N Engl J Med 292 1975 344 347
2. A. Bohan J.B. Peter R.L. Bowman A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis Medicine 56 1977 255
3. J.P. Callen Management of antimalarial-refractory cutaneous lupus erythematosus Lupus 6 1997 203 208
4. J.P. Callen Chronic cutaneous LE Arch Dermatol 118 1982 412 416
5. J.P. Callen D.L. Tuffanelli T.T. Provost Collagen-vascular disease: An update J Am Acad Dermatol 28 1993 477 484
6. P.M. Campbell E.C. Leroy Raynaud phenomenon Semin Arthritis Rheum 16 1986 92 103
7. J.V. Campellone D. Lacomis M.J. Giulani Percutaneous needle muscle biopsy in the evaluation of patients with suspected inflammatory myopathy Arthritis Rheum 40 1997 1886 1891
8. P. Cherin J.C. Piette S. Herson Dermatomyositis and ovarian cancer: A report of 7 cases and literature review J Rheumatol 20 1993 1897 1899
9. Chow W.-H. G. Gridley L. Mellemkjaer Cancer risk following polymyositis and dermatomyositis: A nationwide cohort study in Denmark Cancer Causes Control 6 1995 9 13
10. A.N. Crowson C.M. Magro Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy Hum Pathol 28 1997 67 73
11. J. Cukier R.A. Beauchamp J.S. Spindler Association between bovine collagen implants and a dermatomyositis or polymyositis-like syndrome Ann Intern Med 118 1993 920 928
12. M.C. Dalakas I. Illa J.M. Dambrosia A controlled trial of high-dose intravenous immune globulin infusions as a treatment for dermatomyositis N Engl J Med 329 1993 1993 2000
13. K.M. David-Bajar Subacute cutaneous lupus erythematosus J Invest Dermatol 100 1993 2S 8S
14. R.L. Euwer R.D. Sontheimer Amyopathic dermatomyositis (dermatomyositis siné myositis) J Am Acad Dermatol 24 1991 959 966
15. V.C. Fabré S. Lear M. Reichlin Twenty percent of biopsy specimens from sun-exposed skin of normal young adults demonstrate positive immunofluorescence Arch Dermatol 127 1991 1006 1011
16. V. Falanga Localized scleroderma Med Clin North Am 73 1989 1143 1156
17. J.N. Gilliam R.D. Sontheimer Distinctive cutaneous subsets in the spectrum of lupus erythematosus J Am Acad Dermatol 4 1981 471 475
18. C. Gruss J.A. Reed P. Altmeyer Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts Lancet 350 1997 1295 1296
19. P. Humbert E. Delaporte J.L. Dupond Treatment of localized scleroderma with oral 1,25-dihydroxyvitamin D3 Eur J Dermatol 4 1994 21 23
20. J.S. Kasteler J.P. Callen Scalp involvement in dermatomyositis: Often overlooked or misdiagnosed JAMA 272 1994 1939 1941
21. J.S. Kasteler J.P. Callen Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis J Am Acad Dermatol 36 1997 67 71
22. S. Krnic-Barrie C.R. O'Connor S.W. Looney A retrospective review of 61 patients with antiphospholipid syndrome Arch Intern Med 157 1997 2102 2108
23. L.A. Lee K.M. David Cutaneous lupus erythematosus Curr Probl Dermatol 1 1989 161 200
24. P. Lehmann E. Hölzle P. Kind Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation J Am Acad Dermatol 22 1990 181 187
25. M. Petri Antiphospholipid antibodies: Lupus anticoagulant and anticardiolipin antibody Curr Probl Dermatol 4 1992 171 201
26. J.R. Siebold D.E. Furst P.J. Clements Why everything (or nothing) seems to work in the treatment of scleroderma J Rheumatol 19 1992 673 676
27. B. Siguregeirsson B. Lindelöf O. Edhag Risk of cancer in patients with dermatomyositis or polymyositis N Engl J Med 326 1992 363 367
28. P. Sinoway J.P. Callen Chlorambucil: An effective corticosteroid sparing agent for patients with recalcitrant dermatomyositis Arthritis Rheum 36 1993 319 324
29. R.D. Sontheimer D.P. McCauliffe E. Zappi Antinuclear antibodies: Clinical correlations and biologic significance Adv Dermatol 7 1991 3 53
30. C.R. Spann J.P. Callen J.B. Klein Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and/or hypertrophic skin lesions J Rheumatol 15 1988 256 261
31. V.D. Steen G.L. Ziegler G.P. Rodnan Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis Arthritis Rheum 27 1984 125 131
32. H. Stege M. Berneburg S. Humke High-dose UVA-1 radiation therapy for localized scleroderma J Am Acad Dermatol 36 1997 938 944
33. M.R. Stonecipher J.L. Jorizzo W.L. White Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: Dermatomyositis sine myositis? J Am Acad Dermatol 28 1993 951 956
34. L.A. Swygert E.E. Back S.E. Auerbach Eosinophilia-myalgia syndrome: Mortality data from the US national surveillance system J Rheumatol 20 1993 1711 1717
35. E.M. Tan A.S. Cohen J.F. Fries The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1982 1271 1277
36. I.N. Targoff Dermatomyositis and polymyositis Curr Probl Dermatol 3 1991 131 180
37. S.E. Whitmore G.J. Anhalt T.T. Provost Serum CA-125 screening for ovarian cancer in patients with dermatomyositis Gynecol Oncol 65 1997 241 244
38. T.Y. Woo J.P. Callen J.V. Voorhees Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine J Am Acad Dermatol 10 1984 592 600